Cargando…
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 23 different topics selected by each member of the...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043146/ https://www.ncbi.nlm.nih.gov/pubmed/35471681 http://dx.doi.org/10.1186/s41181-022-00162-3 |
| _version_ | 1784694814899437568 |
|---|---|
| author | Bernardes, Emerson Caravan, Peter van Dam, R. Michael Deuther-Conrad, Winnie Ellis, Beverley Furumoto, Shozo Guillet, Benjamin Huang, Ya-Yao Jia, Hongmei Laverman, Peter Li, Zijing Liu, Zhaofei Lodi, Filippo Miao, Yubin Perk, Lars Schirrmacher, Ralf Vercoullie, Johnny Yang, Hua Yang, Min Yang, Xing Zhang, Junbo Zhang, Ming-Rong Zhu, Hua |
| author_facet | Bernardes, Emerson Caravan, Peter van Dam, R. Michael Deuther-Conrad, Winnie Ellis, Beverley Furumoto, Shozo Guillet, Benjamin Huang, Ya-Yao Jia, Hongmei Laverman, Peter Li, Zijing Liu, Zhaofei Lodi, Filippo Miao, Yubin Perk, Lars Schirrmacher, Ralf Vercoullie, Johnny Yang, Hua Yang, Min Yang, Xing Zhang, Junbo Zhang, Ming-Rong Zhu, Hua |
| author_sort | Bernardes, Emerson |
| collection | PubMed |
| description | BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. CONCLUSION: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry. |
| format | Online Article Text |
| id | pubmed-9043146 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90431462022-05-07 Highlight selection of radiochemistry and radiopharmacy developments by editorial board Bernardes, Emerson Caravan, Peter van Dam, R. Michael Deuther-Conrad, Winnie Ellis, Beverley Furumoto, Shozo Guillet, Benjamin Huang, Ya-Yao Jia, Hongmei Laverman, Peter Li, Zijing Liu, Zhaofei Lodi, Filippo Miao, Yubin Perk, Lars Schirrmacher, Ralf Vercoullie, Johnny Yang, Hua Yang, Min Yang, Xing Zhang, Junbo Zhang, Ming-Rong Zhu, Hua EJNMMI Radiopharm Chem Review BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. CONCLUSION: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry. Springer International Publishing 2022-04-26 /pmc/articles/PMC9043146/ /pubmed/35471681 http://dx.doi.org/10.1186/s41181-022-00162-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Review Bernardes, Emerson Caravan, Peter van Dam, R. Michael Deuther-Conrad, Winnie Ellis, Beverley Furumoto, Shozo Guillet, Benjamin Huang, Ya-Yao Jia, Hongmei Laverman, Peter Li, Zijing Liu, Zhaofei Lodi, Filippo Miao, Yubin Perk, Lars Schirrmacher, Ralf Vercoullie, Johnny Yang, Hua Yang, Min Yang, Xing Zhang, Junbo Zhang, Ming-Rong Zhu, Hua Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_full | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_fullStr | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_full_unstemmed | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_short | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_sort | highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043146/ https://www.ncbi.nlm.nih.gov/pubmed/35471681 http://dx.doi.org/10.1186/s41181-022-00162-3 |
| work_keys_str_mv | AT bernardesemerson highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT caravanpeter highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT vandamrmichael highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT deutherconradwinnie highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT ellisbeverley highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT furumotoshozo highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT guilletbenjamin highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT huangyayao highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT jiahongmei highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT lavermanpeter highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT lizijing highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT liuzhaofei highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT lodifilippo highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT miaoyubin highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT perklars highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT schirrmacherralf highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT vercoulliejohnny highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT yanghua highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT yangmin highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT yangxing highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT zhangjunbo highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT zhangmingrong highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT zhuhua highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard |